SlideShare a Scribd company logo
1 of 18
Download to read offline
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Grand Rounds
Sarah Bertini,
APNC
Rebekah King, APNC
Aldo Calvo D.O
Topic: Age-Friendly Health Systems:
Chronic Obstructive Pulmonary Disease (COPD) in the Older Adult
Feel free to chat in the chat box. Remember
to change your chat to ‘Everyone’ so we may
all benefit from your comments.
To Unmute your line: Click on your screen
and then the microphone at the top of screen.
Then click Unmute Call
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Providing Age-Friendly Care
The goal is for all care with older adults to be Age-Friendly care, which:
• Follows an essential set of evidence-based practices;
• Causes no harm; and
• Aligns with What Matters to the older adult and their family caregivers.
AFHS-specific Grand Rounds cases focus on the 4Ms Framework as it pertains to patients 65 years of age and older
What Matters, Medication, Mentation, and Mobility will be addressed as a set and ASSESSED and ACTED ON in each
case scenario. The 4Ms include:
• What Matters: Know, align and act on each older adult’s specific health outcome goals and care preferences
• Medication: Optimize medication use to reduce harm and burden, focusing on medications affecting mobility, mentation,
and what matters; If medication is necessary, use Age-Friendly medication that does not interfere with What Matters to the
older adult, Mobility, or Mentation
• Mentation: Focus to prevent, identify, treat, and manage dementia, depression and delirium in older adults
• Mobility: Focus to maintain mobility and function and prevent/treat complications of immobility in older adults; Ensure that
older adults move safely in order to maintain function and do What Matters
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
How to Integrate 4Ms Care into the Clinic Visit
What Matters: These are some guiding questions or statements to help patients discuss what matters most to them:
• What is most important for you during today’s visit?
• What are you looking forward to this week?
• What activities do you enjoy? If applicable, can ask: What is preventing patient from accomplishing tasks or participating in activities?
• Consider discussion about advance care planning if appropriate for the visit
• During development of care plan: I would like to individualize your treatment with what matters most to you
Medication
• Ask about all prescriptions: prescribed, over-the-counter, laxatives, vitamins, supplements, herbal remedies
• Reconcile medications with electronic health record
• Cross-check for medications that may be on the AGS Beers© Criteria list
Mentation
• Assess patient’s ability to register, use kiosk, follow directions
• Screen for depression using the PHQ-2© and, if positive, continue with the PHQ-9©
• Screen for dementia using the Mini-Cog™
• Assess for delirium for any acute change in mental status using the Confusion Assessment Method
Mobility
• Assess mobility, gait, gait speed, balance, footwear beginning when the patient walks in using the Modified Get Up and Go test
• Assess hand dexterity, fine motor movements as patient removes insurance cards from wallet or writes or signs name
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Learning Objectives
At the end of this session, providers will be able to:
• Recognize the correlation between impaired oxygen perfusion and mentation and mobility
• Identify the interrelationship of the 4Ms in the context of a chronic condition
• Integrate Age-Friendly care using the 4Ms Framework in care of older adults 65 years of age and over
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Case Scenario: COPD Exacerbation
(S) Situation: Linda is a 69 y/o female with complaint of productive cough and dyspnea worsening over the past week. States
that a “cough is normal” for her but over the past week it has become more frequent and more productive. Has productive
cough while in clinic and expectorates a half-dollar size amount of purulent, thick sputum. Also reports nasal congestion,
paroxysmal nocturnal dyspnea, chest tightness, and headache. She denies having a current PCP and states that she hasn’t
seen a doctor in over 2 years. Her husband encouraged her to come in today but she was hesitant because she “doesn’t like
doctors.”
(B) Background: PMH: COPD and GERD
COPD was diagnosed by past PCP. Patient denies ever completing pulmonary function testing. Her PCP “just told her she had
COPD.” She had been on “a couple of inhalers” but stopped taking them over a year ago due to cost. Has Medicare Part A
and Part B, not Part D insurance so medications are not covered.
Medications: Over-the-counter omeprazole 20mg PO daily. Allergic to Penicillin.
Family history: Negative for COPD and lung cancer
Social history: History of 50 pack years of smoking, quit 2 years ago. Denies current or past e-cigarette use, illicit drug use.
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Case Scenario: COPD Exacerbation (Cont.)
(A) Assessment: VS: BP 104/76 mmHg, Pulse 90/min, RR 24/min, Temp 98.5F, SpO2 93% on room air
Mentation: PHQ-2 = 2 (negative), Mini-Cog = 5 (negative)
Mobility: Patient walks in unassisted wearing appropriate footwear. Get Up and Go test: No difficulty getting up from a chair,
walking 10 feet, turning around, walking back, and sitting back in chair.
Skin: Mildly pale, warm, cap refill <3 sec
HEENT: Pupils equal, round and reactive to light, extraocular movements intact; Bilateral tympanic membranes intact, no
erythema or bulging; rhinorrhea present; posterior oropharynx moist with mild cobblestone appearance, no exudate noted
Respiratory: Increased respiratory effort with walking, effort within normal limits while at rest. Tachypnea. Inspiratory and
expiratory wheezes noted in lower fields bilaterally. No rhonchi or crackles noted. No tripoding or use of accessory muscles.
Cardiovascular: Regular rate and rhythm, S1, S2, no peripheral edema noted
(R) Recommendation: Let’s discuss…
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Case Scenario Recommendation
Recommendation:
COPD with acute lower respiratory infection (J44.0)
• Prednisone 40mg PO daily x 5 days
• Albuterol inhaler with spacer 1-2 puffs Q 4-6 hours PRN wheezing, shortness of breath
• Doxycycline 100 mg 1 tablet PO twice a day x 7 days
• Follow up phone call in 48 hours
• Follow up appointment in 1 week at MinuteClinic
COPD Management
• Patient in need of primary care provide and pulmonary function tests
• Discussed What Matters to the patient regarding what she is looking for in a primary care provider. A referral was given to a
geriatric specialist in the area. Patient scheduled a visit and was seen within 10 days.
• Pulmonary function tests were completed and patient was diagnosed with Moderate COPD (GOLD 2)
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Information about COPD
Chronic obstructive pulmonary disease (COPD) is a common respiratory condition
High level of resource utilization
• Frequent office visits, recurrent hospitalizations due to acute exacerbations and need for chronic therapies (i.e.
inhalers, oxygen)
The pathological changes that occur as a result of COPD include:
• Mucus gland hyperplasia
• Fibrosis, narrowing and reduction in the number of small airways and
• Airway collapse
• Chronic inflammation
• Increased number of goblet cells
Three cardinal symptoms of COPD: dyspnea, chronic cough and sputum production
• Most common early symptom: exertional dyspnea
Source: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report.
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
COPD Resources: Global Initiative for COPD GOLD Report
Global Initiative for Chronic Obstructive Lung Disease. (2020). Global Strategy for the Diagnosis,
Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD)
2020 Report. Available at: https://goldcopd.org/gold-reports
Refer to the GOLD Report for evidence-based information related to evidence-based diagnosis,
management and prevention of COPD
This report includes assessment tools. Example: CAT™ COPD Assessment Tool has the patient rate
symptoms from 1 to 5. The higher the score, the more significant the symptom(s).
• I never cough (1) ….. I cough all the time (5)
• I have no phlegm (mucus) in my chest at all (1) ….. My chest is complete full of phlegm (mucus) (5)
• My chest does not feel tight at all (1) ….. My chest feels very tight (5)
• When I walk up a hill or flight of stairs I am not breathless (1) ….. When I walk up a hill or flight of stairs I am
very breathless (5)
• I am not limited doing any activities at home (1) ….. I am very limited doing activities at home (5)
• I am confident leaving my home despite my lung condition (1) ….. I am not at all confident leaving my home
because of my lung condition (5)
• I sleep soundly (1) ….. I don’t sleep soundly because of my lung condition (5)
• I have lots of energy (1) ….. I have no energy at all (5)
Source: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report.
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Case Scenario: Discussion
• What other pharmacological treatments could have been applied for this patient?
• If the patient was not able to establish care with a PCP how would that have changed the treatment plan?
• What patient education should be addressed with a patient with COPD?
Let’s discuss each of these questions further…
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
What other pharmacological treatments could have been applied for
this patient?
• Short-acting anticholinergic inhaler (i.e. Ipratropium bromide): Research has found that a
combination of a Short-Acting Beta Agonist (SABA) and anticholinergic inhaler results in more
bronchodilation than either agent used alone
• Introduce the possibility of including the CAT™ Assessment Tool score
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
If the patient was not able to establish care with a PCP, how would
that change the treatment plan?
At 1 week follow-up the provider could start maintenance therapy and collaborate with a PCP:
• Long-Acting Muscarinic Antagonist (LAMA or long-acting anticholinergic)
i.e. tiotropium (Spiriva) 18mcg (1 capsule) inhaler daily
• Follow up in 6 weeks if still no PCP
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
What educational topics/chronic care items should be addressed
with each patient that has a history of COPD?
Inhaler Technique
• Clinician should demonstrate correct technique, observe patient practice and provide correction if needed
• Medication adjustments should NOT be made unless a review of inhaler technique has been completed to verify the patient is
administering the medication correctly
• Address cost of medications and seek input from pharmacist for lower priced appropriate alternatives
Smoking Cessation
• Smoking cessation can reduce the rate of decline in lung function
• Best cessation rates are achieved when counseling is combined with medication therapy
• Address e-cigarette use
Vaccinations
• Infection is a common cause of COPD exacerbations. Influenza and pneumococcal vaccines should be offered and encouraged to
all patients with COPD.
Making End-of-Life Decisions
• End-of-life discussions are important and part of care provision and What Matters to the patient
• End-of-life care planning should include discussions with the patient and their families about their views on resuscitation, advance
directives, artificial methods of feeding, and place of death preferences
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Back to the case…
Summary: ASSESS and ACT ON the 4Ms as a set
What Matters: Know and act on each patient’s specific health outcome goals and care preferences
• Refer to primary care provider she trusts and will see
• Ability to afford medication: Encourage to apply for Medicare Part D insurance supplement and review pharmacy cost saving options
• Individualize plan to address cost and access to health care and affordable medications
• Consider advance care planning discussion
Medication: Optimize use to reduce harm and burden, focusing on medications affecting mobility, mentation, and what matters
• Choose medications that are most affordable and assure proper use; Educate patient to review inhaler use with pharmacist
Mentation: Focus on dementia and depression and delirium
• Promote adequate SpO2 to prevent change in mentation
• Decrease dyspnea and COPD exacerbations to prevent depression and delirium
• Educate patient and family that in older adults COPD exacerbation and/or respiratory infection may present as delirium
Mobility: Maintain mobility and function and prevent/treat complications of immobility
• Increase mobility; Walk multiple times daily; Physical therapy to promote mobility; Decrease episodes of dyspnea
Provide 4Ms brochure with suggestions for patient/family to share with primary care provider, methods to prevent COPD exacerbation-
• Don’t forget to scan into the EHR whenever individualized.
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Interprofessional Team Discussion…
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Acknowledgements
Age-Friendly Health Systems is an initiative of The John A. Hartford Foundation and the Institute for Healthcare
Improvement (IHI) in partnership with the American Hospital Association (AHA) and the Catholic Health
Association of the United States (CHA).
MinuteClinic’s commitment to be an Age-Friendly Health System is supported by a grant from The John A.
Hartford Foundation to the Case Western Reserve University Frances Payne Bolton School of Nursing.
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
References
1. Han, MK, Dransfield, MT, Martinez, FJ. Chronic Obstructive Pulmonary Disease: Definition, clinical manifestations, diagnosis and staging. Up
To Date. https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-
staging?source=autocomplete&index=3~4&search=copd. Updated May 14, 2018. Accessed July 10, 2019.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic
Obstructive Pulmonary Disease: 2020 Report. www.goldcopd.org. Accessed February 23, 2020.
3. McDonough, JE, Yuan R, Suzuki, M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med
2011; 365:1567
4. Ferguson, GT, Make, B. Management of stable chronic obstructive pulmonary disease. Up To Date.
https://www.uptodate.com/contents/management-of-stable-chronic-obstructive-pulmonary-
disease?source=autocomplete&index=2~4&search=copd. Updated January 16, 2019. Accessed July 10, 2019.
5. Warnier, MJ, vanReit, EE, Rutten, FH, et al. Smoking cessation strategies in patients with COPD. Eur Respir J 2013; 41:727.
Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020.
Thank You

More Related Content

Similar to GR AFHS COPD.7.8.2020 -FINAL wo CE for ho.pptx

GR AFHS Shingles 4.22.21-ho version wo CH.pptx
GR AFHS Shingles 4.22.21-ho version wo CH.pptxGR AFHS Shingles 4.22.21-ho version wo CH.pptx
GR AFHS Shingles 4.22.21-ho version wo CH.pptxAFHSResources
 
GR AFHS DM- HO version wo CE.pptx
GR AFHS DM- HO version wo CE.pptxGR AFHS DM- HO version wo CE.pptx
GR AFHS DM- HO version wo CE.pptxAFHSResources
 
Making COPPER Out of GOLD
Making COPPER Out of GOLDMaking COPPER Out of GOLD
Making COPPER Out of GOLDMike Aref
 
GR AFHS DDD- HO version wo CE.pptx
GR AFHS DDD- HO version wo CE.pptxGR AFHS DDD- HO version wo CE.pptx
GR AFHS DDD- HO version wo CE.pptxAFHSResources
 
Point of-Care Resources & Tools SC
Point of-Care Resources & Tools SCPoint of-Care Resources & Tools SC
Point of-Care Resources & Tools SCImad Hassan
 
GR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptx
GR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptxGR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptx
GR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptxAFHSResources
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementHealth Informatics New Zealand
 
How and when to diagnose Cystic Fibrosis
How and when to diagnose Cystic FibrosisHow and when to diagnose Cystic Fibrosis
How and when to diagnose Cystic FibrosisKaustubhMohite4
 
Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...
Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...
Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...Juarezer
 
Medical surgical exam.docx
Medical surgical exam.docxMedical surgical exam.docx
Medical surgical exam.docxOlayaMohamed
 
RCSLT-Webinar-The-Rehab-Pathway-562020.pdf
RCSLT-Webinar-The-Rehab-Pathway-562020.pdfRCSLT-Webinar-The-Rehab-Pathway-562020.pdf
RCSLT-Webinar-The-Rehab-Pathway-562020.pdfDevalYogi1
 
Day 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittengerDay 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittengerNorton Healthcare
 
The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...
The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...
The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...Pan London Airways Network
 

Similar to GR AFHS COPD.7.8.2020 -FINAL wo CE for ho.pptx (20)

GR AFHS Shingles 4.22.21-ho version wo CH.pptx
GR AFHS Shingles 4.22.21-ho version wo CH.pptxGR AFHS Shingles 4.22.21-ho version wo CH.pptx
GR AFHS Shingles 4.22.21-ho version wo CH.pptx
 
GR AFHS DM- HO version wo CE.pptx
GR AFHS DM- HO version wo CE.pptxGR AFHS DM- HO version wo CE.pptx
GR AFHS DM- HO version wo CE.pptx
 
Making COPPER Out of GOLD
Making COPPER Out of GOLDMaking COPPER Out of GOLD
Making COPPER Out of GOLD
 
GR AFHS DDD- HO version wo CE.pptx
GR AFHS DDD- HO version wo CE.pptxGR AFHS DDD- HO version wo CE.pptx
GR AFHS DDD- HO version wo CE.pptx
 
Ethics, DNR & end-of-life in the era of COVID-19
Ethics, DNR & end-of-life in the era of COVID-19Ethics, DNR & end-of-life in the era of COVID-19
Ethics, DNR & end-of-life in the era of COVID-19
 
Point of-Care Resources & Tools SC
Point of-Care Resources & Tools SCPoint of-Care Resources & Tools SC
Point of-Care Resources & Tools SC
 
RDD 2020 Day 1 AM: Sophie Bernard
RDD 2020  Day 1 AM: Sophie BernardRDD 2020  Day 1 AM: Sophie Bernard
RDD 2020 Day 1 AM: Sophie Bernard
 
CF PPT.pptx
CF PPT.pptxCF PPT.pptx
CF PPT.pptx
 
GR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptx
GR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptxGR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptx
GR AFHS Diff Venous Stasis Derm from Cellulitis.-w-o CH.pptx
 
Caring for COPD
Caring for COPDCaring for COPD
Caring for COPD
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout management
 
Covid and Mental Health: Leadership Essentials
Covid and Mental Health: Leadership EssentialsCovid and Mental Health: Leadership Essentials
Covid and Mental Health: Leadership Essentials
 
How and when to diagnose Cystic Fibrosis
How and when to diagnose Cystic FibrosisHow and when to diagnose Cystic Fibrosis
How and when to diagnose Cystic Fibrosis
 
Covid 19 Syndemic Impact on Mental Health
Covid 19 Syndemic Impact on Mental HealthCovid 19 Syndemic Impact on Mental Health
Covid 19 Syndemic Impact on Mental Health
 
Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...
Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...
Winninghams Critical Thinking Cases in Nursing 5th Edition Harding Solutions ...
 
Medical surgical exam.docx
Medical surgical exam.docxMedical surgical exam.docx
Medical surgical exam.docx
 
Management of ari
Management of ariManagement of ari
Management of ari
 
RCSLT-Webinar-The-Rehab-Pathway-562020.pdf
RCSLT-Webinar-The-Rehab-Pathway-562020.pdfRCSLT-Webinar-The-Rehab-Pathway-562020.pdf
RCSLT-Webinar-The-Rehab-Pathway-562020.pdf
 
Day 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittengerDay 1 | CME- Trauma Symposium | Bronchiolitis pittenger
Day 1 | CME- Trauma Symposium | Bronchiolitis pittenger
 
The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...
The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...
The Breathing Space Clinic …a multi-disciplinary, inter-organisational hospi...
 

Recently uploaded

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 

Recently uploaded (20)

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 

GR AFHS COPD.7.8.2020 -FINAL wo CE for ho.pptx

  • 1. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Grand Rounds Sarah Bertini, APNC Rebekah King, APNC Aldo Calvo D.O Topic: Age-Friendly Health Systems: Chronic Obstructive Pulmonary Disease (COPD) in the Older Adult Feel free to chat in the chat box. Remember to change your chat to ‘Everyone’ so we may all benefit from your comments. To Unmute your line: Click on your screen and then the microphone at the top of screen. Then click Unmute Call
  • 2. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Providing Age-Friendly Care The goal is for all care with older adults to be Age-Friendly care, which: • Follows an essential set of evidence-based practices; • Causes no harm; and • Aligns with What Matters to the older adult and their family caregivers. AFHS-specific Grand Rounds cases focus on the 4Ms Framework as it pertains to patients 65 years of age and older What Matters, Medication, Mentation, and Mobility will be addressed as a set and ASSESSED and ACTED ON in each case scenario. The 4Ms include: • What Matters: Know, align and act on each older adult’s specific health outcome goals and care preferences • Medication: Optimize medication use to reduce harm and burden, focusing on medications affecting mobility, mentation, and what matters; If medication is necessary, use Age-Friendly medication that does not interfere with What Matters to the older adult, Mobility, or Mentation • Mentation: Focus to prevent, identify, treat, and manage dementia, depression and delirium in older adults • Mobility: Focus to maintain mobility and function and prevent/treat complications of immobility in older adults; Ensure that older adults move safely in order to maintain function and do What Matters
  • 3. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. How to Integrate 4Ms Care into the Clinic Visit What Matters: These are some guiding questions or statements to help patients discuss what matters most to them: • What is most important for you during today’s visit? • What are you looking forward to this week? • What activities do you enjoy? If applicable, can ask: What is preventing patient from accomplishing tasks or participating in activities? • Consider discussion about advance care planning if appropriate for the visit • During development of care plan: I would like to individualize your treatment with what matters most to you Medication • Ask about all prescriptions: prescribed, over-the-counter, laxatives, vitamins, supplements, herbal remedies • Reconcile medications with electronic health record • Cross-check for medications that may be on the AGS Beers© Criteria list Mentation • Assess patient’s ability to register, use kiosk, follow directions • Screen for depression using the PHQ-2© and, if positive, continue with the PHQ-9© • Screen for dementia using the Mini-Cog™ • Assess for delirium for any acute change in mental status using the Confusion Assessment Method Mobility • Assess mobility, gait, gait speed, balance, footwear beginning when the patient walks in using the Modified Get Up and Go test • Assess hand dexterity, fine motor movements as patient removes insurance cards from wallet or writes or signs name
  • 4. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Learning Objectives At the end of this session, providers will be able to: • Recognize the correlation between impaired oxygen perfusion and mentation and mobility • Identify the interrelationship of the 4Ms in the context of a chronic condition • Integrate Age-Friendly care using the 4Ms Framework in care of older adults 65 years of age and over
  • 5. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Case Scenario: COPD Exacerbation (S) Situation: Linda is a 69 y/o female with complaint of productive cough and dyspnea worsening over the past week. States that a “cough is normal” for her but over the past week it has become more frequent and more productive. Has productive cough while in clinic and expectorates a half-dollar size amount of purulent, thick sputum. Also reports nasal congestion, paroxysmal nocturnal dyspnea, chest tightness, and headache. She denies having a current PCP and states that she hasn’t seen a doctor in over 2 years. Her husband encouraged her to come in today but she was hesitant because she “doesn’t like doctors.” (B) Background: PMH: COPD and GERD COPD was diagnosed by past PCP. Patient denies ever completing pulmonary function testing. Her PCP “just told her she had COPD.” She had been on “a couple of inhalers” but stopped taking them over a year ago due to cost. Has Medicare Part A and Part B, not Part D insurance so medications are not covered. Medications: Over-the-counter omeprazole 20mg PO daily. Allergic to Penicillin. Family history: Negative for COPD and lung cancer Social history: History of 50 pack years of smoking, quit 2 years ago. Denies current or past e-cigarette use, illicit drug use.
  • 6. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Case Scenario: COPD Exacerbation (Cont.) (A) Assessment: VS: BP 104/76 mmHg, Pulse 90/min, RR 24/min, Temp 98.5F, SpO2 93% on room air Mentation: PHQ-2 = 2 (negative), Mini-Cog = 5 (negative) Mobility: Patient walks in unassisted wearing appropriate footwear. Get Up and Go test: No difficulty getting up from a chair, walking 10 feet, turning around, walking back, and sitting back in chair. Skin: Mildly pale, warm, cap refill <3 sec HEENT: Pupils equal, round and reactive to light, extraocular movements intact; Bilateral tympanic membranes intact, no erythema or bulging; rhinorrhea present; posterior oropharynx moist with mild cobblestone appearance, no exudate noted Respiratory: Increased respiratory effort with walking, effort within normal limits while at rest. Tachypnea. Inspiratory and expiratory wheezes noted in lower fields bilaterally. No rhonchi or crackles noted. No tripoding or use of accessory muscles. Cardiovascular: Regular rate and rhythm, S1, S2, no peripheral edema noted (R) Recommendation: Let’s discuss…
  • 7. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Case Scenario Recommendation Recommendation: COPD with acute lower respiratory infection (J44.0) • Prednisone 40mg PO daily x 5 days • Albuterol inhaler with spacer 1-2 puffs Q 4-6 hours PRN wheezing, shortness of breath • Doxycycline 100 mg 1 tablet PO twice a day x 7 days • Follow up phone call in 48 hours • Follow up appointment in 1 week at MinuteClinic COPD Management • Patient in need of primary care provide and pulmonary function tests • Discussed What Matters to the patient regarding what she is looking for in a primary care provider. A referral was given to a geriatric specialist in the area. Patient scheduled a visit and was seen within 10 days. • Pulmonary function tests were completed and patient was diagnosed with Moderate COPD (GOLD 2)
  • 8. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Information about COPD Chronic obstructive pulmonary disease (COPD) is a common respiratory condition High level of resource utilization • Frequent office visits, recurrent hospitalizations due to acute exacerbations and need for chronic therapies (i.e. inhalers, oxygen) The pathological changes that occur as a result of COPD include: • Mucus gland hyperplasia • Fibrosis, narrowing and reduction in the number of small airways and • Airway collapse • Chronic inflammation • Increased number of goblet cells Three cardinal symptoms of COPD: dyspnea, chronic cough and sputum production • Most common early symptom: exertional dyspnea Source: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report.
  • 9. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. COPD Resources: Global Initiative for COPD GOLD Report Global Initiative for Chronic Obstructive Lung Disease. (2020). Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 Report. Available at: https://goldcopd.org/gold-reports Refer to the GOLD Report for evidence-based information related to evidence-based diagnosis, management and prevention of COPD This report includes assessment tools. Example: CAT™ COPD Assessment Tool has the patient rate symptoms from 1 to 5. The higher the score, the more significant the symptom(s). • I never cough (1) ….. I cough all the time (5) • I have no phlegm (mucus) in my chest at all (1) ….. My chest is complete full of phlegm (mucus) (5) • My chest does not feel tight at all (1) ….. My chest feels very tight (5) • When I walk up a hill or flight of stairs I am not breathless (1) ….. When I walk up a hill or flight of stairs I am very breathless (5) • I am not limited doing any activities at home (1) ….. I am very limited doing activities at home (5) • I am confident leaving my home despite my lung condition (1) ….. I am not at all confident leaving my home because of my lung condition (5) • I sleep soundly (1) ….. I don’t sleep soundly because of my lung condition (5) • I have lots of energy (1) ….. I have no energy at all (5) Source: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report.
  • 10. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Case Scenario: Discussion • What other pharmacological treatments could have been applied for this patient? • If the patient was not able to establish care with a PCP how would that have changed the treatment plan? • What patient education should be addressed with a patient with COPD? Let’s discuss each of these questions further…
  • 11. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. What other pharmacological treatments could have been applied for this patient? • Short-acting anticholinergic inhaler (i.e. Ipratropium bromide): Research has found that a combination of a Short-Acting Beta Agonist (SABA) and anticholinergic inhaler results in more bronchodilation than either agent used alone • Introduce the possibility of including the CAT™ Assessment Tool score
  • 12. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. If the patient was not able to establish care with a PCP, how would that change the treatment plan? At 1 week follow-up the provider could start maintenance therapy and collaborate with a PCP: • Long-Acting Muscarinic Antagonist (LAMA or long-acting anticholinergic) i.e. tiotropium (Spiriva) 18mcg (1 capsule) inhaler daily • Follow up in 6 weeks if still no PCP
  • 13. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. What educational topics/chronic care items should be addressed with each patient that has a history of COPD? Inhaler Technique • Clinician should demonstrate correct technique, observe patient practice and provide correction if needed • Medication adjustments should NOT be made unless a review of inhaler technique has been completed to verify the patient is administering the medication correctly • Address cost of medications and seek input from pharmacist for lower priced appropriate alternatives Smoking Cessation • Smoking cessation can reduce the rate of decline in lung function • Best cessation rates are achieved when counseling is combined with medication therapy • Address e-cigarette use Vaccinations • Infection is a common cause of COPD exacerbations. Influenza and pneumococcal vaccines should be offered and encouraged to all patients with COPD. Making End-of-Life Decisions • End-of-life discussions are important and part of care provision and What Matters to the patient • End-of-life care planning should include discussions with the patient and their families about their views on resuscitation, advance directives, artificial methods of feeding, and place of death preferences
  • 14. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Back to the case… Summary: ASSESS and ACT ON the 4Ms as a set What Matters: Know and act on each patient’s specific health outcome goals and care preferences • Refer to primary care provider she trusts and will see • Ability to afford medication: Encourage to apply for Medicare Part D insurance supplement and review pharmacy cost saving options • Individualize plan to address cost and access to health care and affordable medications • Consider advance care planning discussion Medication: Optimize use to reduce harm and burden, focusing on medications affecting mobility, mentation, and what matters • Choose medications that are most affordable and assure proper use; Educate patient to review inhaler use with pharmacist Mentation: Focus on dementia and depression and delirium • Promote adequate SpO2 to prevent change in mentation • Decrease dyspnea and COPD exacerbations to prevent depression and delirium • Educate patient and family that in older adults COPD exacerbation and/or respiratory infection may present as delirium Mobility: Maintain mobility and function and prevent/treat complications of immobility • Increase mobility; Walk multiple times daily; Physical therapy to promote mobility; Decrease episodes of dyspnea Provide 4Ms brochure with suggestions for patient/family to share with primary care provider, methods to prevent COPD exacerbation- • Don’t forget to scan into the EHR whenever individualized.
  • 15. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Interprofessional Team Discussion…
  • 16. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Acknowledgements Age-Friendly Health Systems is an initiative of The John A. Hartford Foundation and the Institute for Healthcare Improvement (IHI) in partnership with the American Hospital Association (AHA) and the Catholic Health Association of the United States (CHA). MinuteClinic’s commitment to be an Age-Friendly Health System is supported by a grant from The John A. Hartford Foundation to the Case Western Reserve University Frances Payne Bolton School of Nursing.
  • 17. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. References 1. Han, MK, Dransfield, MT, Martinez, FJ. Chronic Obstructive Pulmonary Disease: Definition, clinical manifestations, diagnosis and staging. Up To Date. https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and- staging?source=autocomplete&index=3~4&search=copd. Updated May 14, 2018. Accessed July 10, 2019. 2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2020 Report. www.goldcopd.org. Accessed February 23, 2020. 3. McDonough, JE, Yuan R, Suzuki, M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365:1567 4. Ferguson, GT, Make, B. Management of stable chronic obstructive pulmonary disease. Up To Date. https://www.uptodate.com/contents/management-of-stable-chronic-obstructive-pulmonary- disease?source=autocomplete&index=2~4&search=copd. Updated January 16, 2019. Accessed July 10, 2019. 5. Warnier, MJ, vanReit, EE, Rutten, FH, et al. Smoking cessation strategies in patients with COPD. Eur Respir J 2013; 41:727.
  • 18. Created in collaboration between MinuteClinic and the Frances Payne Bolton School of Nursing, Case Western Reserve University - 2020. Thank You

Editor's Notes

  1. Today’s topic is: Chronic Obstructive Pulmonary Disease (COPD) in the Older Adult
  2. The goal is for all care with older adults to be Age-Friendly care, which follows an essential set of evidence-based practices, causes no harm, and aligns with What Matters to the older adult and their family caregivers. AFHS-specific Grand Rounds cases will focus on the 4Ms Framework as it pertains to our patients 65 years of age and older. What Matters, Medication, Mentation, and Mobility will be addressed as a set and ASSESSED and ACTED ON in each case scenario. The 4Ms include: What Matters: Know, align and act on each older adult’s specific health outcome goals and care preferences Medication: Optimize medication use to reduce harm and burden, focusing on medications affecting mobility, mentation, and what matters; If medication is necessary, use Age-Friendly medication that does not interfere with What Matters to the older adult, Mobility, or Mentation Mentation: Focus to prevent, identify, treat, and manage dementia, depression and delirium in older adults Mobility: Focus to maintain mobility and function and prevent/treat complications of immobility in older adults; Ensure that older adults move safely in order to maintain function and do What Matters
  3. This slide provides information to help integrate 4Ms care into the clinic visit. This is the basis of providing Age-Friendly care. You will become familiar with the Age-Friendly Health Systems 4Ms Framework logo. What Matters: These are some guiding questions or statements to help patients discuss what matters most to them: What is most important for you during today’s visit? What are you looking forward to this week? What activities do you enjoy? If applicable, can ask: What is preventing patient from accomplishing tasks or participating in activities? Consider discussion about advance care planning if appropriate for the visit During development of care plan: I would like to individualize your treatment with what matters most to you Medication Ask about all prescriptions: prescribed, over-the-counter, laxatives, vitamins, supplements, herbal remedies Reconcile medications with electronic health record Cross-check for medications that may be on the AGS Beers© Criteria list Mentation Assess patient’s ability to register, use kiosk, follow directions Screen for depression using the PHQ-2© and, if positive, continue with the PHQ-9© Screen for dementia using the Mini-Cog™ Assess for delirium for any acute change in mental status using the Confusion Assessment Method Mobility Assess mobility, gait, gait speed, balance, footwear beginning when the patient walks in using the Modified Get Up and Go test Assess hand dexterity, fine motor movements as patient removes insurance cards from wallet or writes or signs name
  4. At the end of this session, providers will be able to: Recognize the correlation between impaired oxygen perfusion and mentation and mobility Identify the interrelationship of the 4Ms in the context of a chronic condition Integrate Age-Friendly care using the 4Ms Framework in care of older adults 65 years of age and over
  5. S: Situation: Linda is a 69 y/o female with complaint of productive cough and dyspnea worsening over the past week. States that a “cough is normal” for her but over the past week it has become more frequent and more productive. Has productive cough while in clinic and expectorates a half-dollar size amount of purulent, thick sputum. Also reports nasal congestion, paroxysmal nocturnal dyspnea, chest tightness, and headache. She denies having a current PCP and states that she hasn’t seen a doctor in over 2 years. Her husband encouraged her to come in today but she was hesitant because she “doesn’t like doctors.”   B: Background: PMH: COPD and GERD. COPD was diagnosed by past PCP. Patient denies ever completing pulmonary function testing. Her PCP “just told her she had COPD.” She had been on “a couple of inhalers” but stopped taking them over a year ago due to cost. Has Medicare Part A and Part B, not Part D insurance so medications are not covered.   Medications: Over-the-counter omeprazole 20mg PO daily. Allergic to Penicillin.   Family history: Negative for COPD and lung cancer   Social history: History of 50 pack years of smoking, quit 2 years ago. Denies current or past e-cigarette use, illicit drug use.
  6. A: Assessment: VS: BP 104/76 mmHg, Pulse 90/min, RR 24/min, Temp 98.5F, SpO2 = 93% on room air   Mentation: PHQ-2 = 2 (negative), Mini-Cog = 5 (negative)   Mobility: Patient walks in unassisted wearing appropriate footwear. Get Up and Go test: No difficulty getting up from a chair, walking 10 feet, turning around, walking back, and sitting back in chair.   Skin: Mildly pale, warm, cap refill <3 sec HEENT: PERRLA, extraocular movements intact; Bilateral tympanic membranes intact, no erythema or bulging; rhinorrhea present; posterior oropharynx moist with mild cobblestone appearance, no exudate noted Respiratory: Increased respiratory effort with walking, effort within normal limits while at rest. Tachypnea. Inspiratory and expiratory wheezes noted in lower fields bilaterally. No rhonchi or crackles noted. No tripoding or use of accessory muscles. Cardiovascular: Regular rate and rhythm, S1, S2, no peripheral edema noted   R: Recommendation: Let’s discuss…
  7. I see the patient is GOLD 2. At MC we categorize them by A,B, C, D. We are able to see patients in category A and B, and treat exacerbations. If they are C or D need referral to higher level of care for treatment of COPD exacerbation and further care. So, we can call this patient a Category B. He is started on Spiriva (Long Acting Anti-Cholinergic), Albuterol Prn, Prednisone burst, Doxy x 7 days for Moderate COPD Exacerbation. Patient needs Steroid Burst (Benefit outweighs risk), but be aware Prednisone is a BEERS med that can cause Delirium. Pt. and family should be advised to watch for it and report right away. Needs to see PCP within 72 hours (per MC GL). R: Recommendation. COPD with acute lower respiratory infection (J44.0) Prednisone 40mg PO daily x 5 days Albuterol inhaler with spacer 1-2 puffs Q 4-6 hours PRN wheezing, shortness of breath Doxycycline 100 mg tablet PO twice a day x 7 days Follow up phone call in 48 hours Follow up appointment in 1 week at MinuteClinic COPD Management Patient in need of medical home and pulmonary function tests Discussed What Matters to the patient regarding what she is looking for in a primary care provider. A referral was given to a geriatric specialist in the area. Patient scheduled a visit and will be seen within 10 days. Pulmonary function tests were completed and patient was diagnosed with Moderate COPD (GOLD 2)
  8. Chronic obstructive pulmonary disease (COPD) is a common respiratory condition that affects more than 5% of the population (1).   COPD is defined by The Global Initiative for Chronic Obstructive Lung Disease (GOLD) as follows (2): “COPD is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases.” Due to the chronic nature and high prevalence of COPD in our communities, patients suffering from this disease have a high level of resource utilization with frequent clinician office visits, recurrent hospitalizations due to acute exacerbations and the need for chronic therapies (i.e. inhalers, oxygen) (1).   The majority of pathological changes that occur as a result of COPD include chronic inflammation, increased number of goblet cells, mucus gland hyperplasia, fibrosis, narrowing and reduction in the number of small airways and airway collapse due to the loss of tethering caused by alveolar wall destruction in emphysema (3).   As a result, the three cardinal symptoms of COPD are dyspnea, chronic cough and sputum production, with the most common early symptom being exertional dyspnea (1).
  9. Global Initiative for Chronic Obstructive Lung Disease. (2020). Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 Report. It is available at the website provided: https://goldcopd.org/gold-reports. Refer to the GOLD Report for evidence-based information related to evidence-based diagnosis, management and prevention of COPD. This report includes The Refined ABCD Assessment Tool and CAT™ COPD Assessment Tool.   The CAT™ COPD Assessment Tool has the patient rate symptoms from 1 to 5. The higher the score, the more significant the symptom(s). Questions include: I never cough (1) ….. I cough all the time (5) I have no phlegm (mucus) in my chest at all (1) ….. My chest is complete full of phlegm (mucus) (5) My chest does not feel tight at all (1) ….. My chest feels very tight (5) When I walk up a hill or flight of stairs I am not breathless (1) ….. When I walk up a hill or flight of stairs I am very breathless (5) I am not limited doing any activities at home (1) ….. I am very limited doing activities at home (5) I am confident leaving my home despite my lung condition (1) ….. I am not at all confident leaving my home because of my lung condition (5) I sleep soundly (1) ….. I don’t sleep soundly because of my lung condition (5) I have lots of energy (1) ….. I have no energy at all (5)
  10. Here are some case scenario questions to consider and help facilitate discussion: What other pharmacological treatments could have been applied for this patient? If the patient was not able to establish care with a primary care provider how would that have changed the treatment plan? What patient education should be addressed with a patient with COPD?   Let’s discuss each of these questions further…
  11. Short-acting anticholinergic inhaler (i.e. Ipratropium bromide): Research has found that a combination of a Short-Acting Beta Agonist (SABA) and anticholinergic inhaler results in more bronchodilation than either agent used alone. Introduce the possibility of including the CAT™ Assessment Tool score.
  12. At 1 week follow-up the provider could start maintenance therapy and collaborate with a primary care provider: Long-Acting Muscarinic Antagonist (LAMA or long-acting anticholinergic) such as tiotropium (Spiriva) 18mcg (1 capsule) inhaler daily Follow up in 6 weeks if still no primary care provider
  13. Inhaler Technique Clinician should demonstrate correct technique, observe patient practice and provide correction if needed (4). Medication adjustments should NOT be made unless a review of inhaler technique has been completed to verify the patient is administering the medication correctly. Address cost of medications and seek input from pharmacist for lower priced appropriate alternatives Smoking Cessation Smoking cessation can reduce the rate of decline in lung function (4). Best cessation rates are achieved when counseling is combined with medication therapy (5). Address any e-cigarette use Vaccinations Infection is a common cause of COPD exacerbations. Influenza and pneumococcal vaccines should be offered and encouraged to all patients with COPD (4). Making End-of-Life Decisions End-of-Life discussions are important and part of care provision and What Matters to the patient. End-of-Life care planning should include discussions with the patient and their families about their views on resuscitation, advance directives, artificial methods of feeding, and place of death preferences (2)
  14. Age-Friendly health care seeks to incorporate all 4Ms (What Matters, Mobility, Medication, Mentation) into your assessment and provision of care of your patients 65 years of age and over. Here are some recommendations referring back to the case. Keep in mind the need to ASSESS and ACT ON the 4Ms as a set. What Matters: Know and act on each patient’s specific health outcome goals and care preferences Refer to primary care provider she trusts and will see Ability to afford medication: Encourage to apply for Medicare Part D insurance supplement and review pharmacy cost saving options Individualize plan to address cost and access to health care and affordable medications Consider advance care planning discussion Medication: Optimize use to reduce harm and burden, focusing on medications affecting mobility, mentation, and what matters Choose medications that are most affordable and assure proper use; Educate patient to review inhaler use with pharmacist Mentation: Focus on dementia and depression and delirium Promote adequate SpO2 to prevent change in mentation Decrease dyspnea and COPD exacerbations to prevent depression and delirium Educate patient and family that in older adults COPD exacerbation and/or respiratory infection may present as delirium Mobility: Maintain mobility and function and prevent/treat complications of immobility Increase mobility; Walk multiple times daily; Physical therapy to promote mobility; Decrease episodes of dyspnea Provide 4Ms brochure with suggestions for patient/family to share with primary care provider, methods to prevent COPD exacerbation Don’t forget to scan the brochure into the EHR whenever individualized.
  15. Team discussion: NP, pharmacist, physician, other Pharmacist Input Goals of treatment in COPD include smoking cessation, decreased symptoms (particularly dyspnea) as measured by the CAT or mMRC, reduction in frequency and severity of exacerbations, reduction rate of acute care utilization and 30-day readmissions, improvement in exercise tolerance and effectiveness of pulmonary rehabilitation, and improvement in Health-Related Quality of Life (HRQOL) as measured by the St. George’s Respiratory Questionnaire (SGRQ). A clinically important difference in the SGRQ is defined as a minimum increase or decrease of 4 units.   Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 Report. Available at: https://goldcopd.org/gold-reports. St. George’s University of London Health Status Research. St. George’s Respiratory Questionnaire. Revised November 22, 2017. Available at: http://www.healthstatus.sgul.ac.uk/sgrq.   Treatment approaches would look at this reference: Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 2017;49:1600791. 10.1183/13993003.00791-2016. Ask contributing physician for input
  16. These are the references cited throughout the presentation: 1. Han, MK, Dransfield, MT, Martinez, FJ. Chronic Obstructive Pulmonary Disease: Definition, clinical manifestations, diagnosis and staging. Up To Date. https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-staging?source=autocomplete&index=3~4&search=copd. Updated May 14, 2018. Accessed July 10, 2019. 2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2020 Report. www.goldcopd.org. Accessed February 23, 2020. 3. McDonough, JE, Yuan R, Suzuki, M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365:1567 4. Ferguson, GT, Make, B. Management of stable chronic obstructive pulmonary disease. Up To Date. https://www.uptodate.com/contents/management-of-stable-chronic-obstructive-pulmonary-disease?source=autocomplete&index=2~4&search=copd. Updated January 16, 2019. Accessed July 10, 2019. 5. Warnier, MJ, vanReit, EE, Rutten, FH, et al. Smoking cessation strategies in patients with COPD. Eur Respir J 2013; 41:727.